| Breakdown | TTM | Mar 2025 | Mar 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 54.42B | 40.85B | 27.44B | 24.67B | 22.70B | 21.30B |
| Gross Profit | 8.25B | 11.48B | 16.74B | 14.54B | 13.20B | 12.55B |
| EBITDA | 21.50B | 21.66B | 18.68B | 17.14B | 15.67B | 14.66B |
| Net Income | 13.47B | 13.82B | 12.02B | 10.35B | 9.27B | 8.89B |
Balance Sheet | ||||||
| Total Assets | 401.02B | 400.13B | 400.09B | 367.53B | 353.68B | 336.30B |
| Cash, Cash Equivalents and Short-Term Investments | 18.18B | 12.83B | 8.17B | 18.70B | 14.77B | 12.08B |
| Total Debt | 204.74B | 204.74B | 204.74B | 188.14B | 181.69B | 172.69B |
| Total Liabilities | 212.67B | 215.95B | 212.26B | 195.54B | 188.46B | 179.01B |
| Stockholders Equity | 188.34B | 187.58B | 187.82B | 172.00B | 165.22B | 157.30B |
Cash Flow | ||||||
| Free Cash Flow | 18.76B | 15.42B | -28.40B | 1.32B | -3.85B | -15.88B |
| Operating Cash Flow | 43.32B | 29.79B | 26.53B | 24.57B | 14.40B | 13.12B |
| Investing Cash Flow | -24.91B | -14.48B | -56.87B | -23.32B | -18.09B | -28.68B |
| Financing Cash Flow | -15.01B | -14.35B | 20.34B | 2.84B | 7.60B | 17.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | ¥352.93B | 9.01 | 6.80% | 5.16% | -27.00% | 18.03% | |
71 Outperform | ¥247.19B | 9.21 | 7.17% | 4.68% | 41.67% | 1.13% | |
67 Neutral | ¥444.23B | 12.99 | 6.81% | 3.58% | 9.83% | 21.66% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | ¥245.54B | 13.13 | ― | 3.47% | 12.95% | 6.80% | |
58 Neutral | ¥316.43B | 13.66 | ― | 3.56% | 6.93% | 7.40% |